Key Facts Surrounding This News Item
- SCPH had returned -37.06% year-to-date leading up to today’s news, versus a +4.94% return from the benchmark S&P 500 during the same period.
More Info About scPharmaceuticals Inc. (SCPH)
scPharmaceuticals Inc. engages in the development and commercialization of transformative pharmaceutical products. The company’s under development products are for heart failure and infectious diseases that include Furoscix that is for treatment of worsening or decompensated heart failure outside of the inpatient setting. scPharmaceuticals Inc. formerly known as scPharmaceuticals LLC. and changed its name to scPharmaceuticals Inc. in March 2014. The company was founded 2013 and is based in Burlington, Massachusetts. View our full SCPH ticker page with ratings, news, and more.